Table 4.
Study Title | Participants | Intervention | Objective | Clinical Trial ID |
---|---|---|---|---|
Does extra virgin olive oil induce gene and metabolic changes in healthy subjects | 40 (healthy with family history of Alzheimer’s disease | 30 mL extra virgin olive oil daily for 6 months | Assess the impact of extra virgin olive oil on the molecular and biological mechanisms associated with AD in healthy individuals with a family history of the disease. | NCT05929924 |
Pilot Study About Extra Virgin Olive Oil “Coratina” in Mild Cognitive Impairment and Alzheimer’s Disease Patients (EVOCAD) | 24 mild cognitive impairment and Alzheimer’s disease patients | Extra virgin olive oil ‘Coratina’ vs. biophenol low-dose olive oil for 12 months | Assess and compare the effects of extra virgin olive oil and biophenol low-dose olive oil on brain and cardiovascular functions. | NCT04229186 |
Auburn University research on olive oil for Alzheimer’s disease (AU-ROOAD) | 24 Mild cognitive impairment patients | Extra-virgin olive oil that is rich with oleocanthal versus phenols and olive oil low in oleocanthal and other phenols, daily for 6 months | Evaluate the effect of extra-virgin olive oil in MCI participants and compare its effect with refined olive oil (ROO; null in phenolic fraction) using a variety of metrics: (i) the blood brain barrier integrity obtained from contrast-enhanced MRI imaging, and brain function and network connectivity obtained by functional MRI (fMRI), (ii) cognitive function assessed using neuropsychological evaluation, and (iii) blood Aβ, tau, phospho-tau 181, and neurofilament light levels. | NCT03824197 |
Greek high-phenolic early harvest extra virgin olive oil in mild cognitive impairment: the MICOIL Pilot Study |
50 mild cognitive impairment patients | High phenolic early-harvest extra virgin olive oil (HP-EH-EVOO) versus moderate-phenolic (MP-EVOO), 50 mL/day, for 12 months | Evaluate the beneficial effect of extra virgin olive oil in comparison to freshly pressed extra virgin olive oil on patients diagnosed with mild cognitive impairment | NCT03362996 |
Attenuation of Postprandial Inflammatory Processes in Alzheimer’s Disease Patients by Consumption of Pomace Oil (CORDIAL) | 80 (40 early-stage Alzheimer’s disease patients, 40 healthy individuals | Olive pomace oil versus high-oleic sunflower oil in the other | Evaluate the effect on triglyceride-rich lipoproteins and neuroinflammation via microglia inactivation | NCT06245616 |
Management of dementia with olive oil leaves (GOLDEN) | 100 mild cognitive impairment patients | Beverage of olive oil from leaves versus dietary supplement: Mediterranean diet, for 24 months |
Evaluate and compare the effects of the olive-leaf beverage and Mediterranean diet on memory and cognitive function in individuals with mild dementia. | NCT04440020 |